$SENS
Senseonics Holdings, Inc. Stock $sens

$sens Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000155837023003952 Filed on March 16, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$4.137M	$5.571M	$16.39M
YoY Change	66.75%	39.0%	19.85%
Cost Of Revenue	$3.723M	$4.952M	$13.66M
YoY Change	90.53%	10.26%	-5.68%
Gross Profit	$400.0K	$619.0K	$2.700M
YoY Change	-24.1%	-228.16%	-432.92%
Gross Profit Margin	9.67%	11.11%	16.47%
Selling, General & Admin	$7.718M	$7.849M	$31.63M
YoY Change	-2.09%	35.16%	17.07%
% of Gross Profit	1929.5%	1268.01%	1171.63%
Research & Development	$12.41M	$11.63M	$39.72M
YoY Change	58.96%	51.94%	45.93%
% of Gross Profit	3101.25%	1879.0%	1471.07%
Depreciation & Amortization	$236.0K	$234.0K	$985.0K
YoY Change	-10.27%	-27.1%	-20.5%
% of Gross Profit	59.0%	37.8%	36.48%
Operating Expenses	$20.12M	$19.48M	$71.35M
YoY Change	28.28%	44.7%	31.56%
Operating Profit	-$19.71M	-$18.86M	-$68.63M
YoY Change	30.01%	35.25%	20.02%
Interest Expense	$4.652M	$30.51M	$18.70M
YoY Change	3.52%	-68.81%	11.86%
% of Operating Profit
Other Income/Expense, Net	$21.03M	$10.00K	$210.7M
YoY Change	-79.35%	-98.19%	-185.92%
Pretax Income	$1.324M	$11.56M	$142.1M
YoY Change	-98.47%	-86.31%	-146.99%
Income Tax	$0.00		$0.00
% Of Pretax Income	0.0%		0.0%
Net Earnings	$1.324M	$11.56M	$142.1M
YoY Change	-98.47%	-86.31%	-146.98%
Net Earnings / Revenue	32.0%	207.52%	867.16%
Basic Earnings Per Share	$0.00		$0.30
Diluted Earnings Per Share	$0.00	$0.02	-$0.11
COMMON SHARES
Basic Shares Outstanding	479.8M	478.3M	468.0M
Diluted Shares Outstanding	540.5M		618.2M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$136.6M	$156.3M	$144.0M
YoY Change	-18.16%	-14.04%	10.86%
Cash & Equivalents	$45.09M	$35.79M	$34.66M
Short-Term Investments	$91.52M	$120.5M	$108.2M
Other Short-Term Assets	$6.163M	$7.092M	$7.092M
YoY Change	-15.47%	22.81%	22.81%
Inventory	$8.195M	$7.306M	$7.306M
Prepaid Expenses
Receivables	$3.404M	$2.451M	$2.451M
Other Receivables	$130.0K	$336.0K	$336.0K
Total Short-Term Assets	$146.3M	$161.2M	$161.2M
YoY Change	-8.87%	11.62%	11.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.042M	$1.112M	$4.144M
YoY Change	-21.06%	-14.98%	216.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$8.157M	$12.25M	$12.25M
YoY Change	-67.56%	-76.38%	-76.38%
Other Assets	$2.998M	$76.00K	$76.00K
YoY Change	184.17%	-94.26%	-94.26%
Total Long-Term Assets	$12.20M	$16.47M	$16.47M
YoY Change	-55.68%	-69.78%	-69.78%
TOTAL ASSETS
Total Short-Term Assets	$146.3M	$161.2M	$161.2M
Total Long-Term Assets	$12.20M	$16.47M	$16.47M
Total Assets	$158.5M	$177.7M	$177.7M
YoY Change	-15.72%	-10.68%	-10.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$646.0K	$419.0K	$419.0K
YoY Change	-69.08%	-65.2%	-65.2%
Accrued Expenses	$13.56M	$15.44M	$15.44M
YoY Change	10.67%	8.26%	8.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$15.58M	$15.58M
YoY Change	-100.0%	432.43%	432.43%
Total Short-Term Liabilities	$14.28M	$31.47M	$31.47M
YoY Change	-54.65%	71.09%	71.09%
LONG-TERM LIABILITIES
Long-Term Debt	$37.48M	$56.38M	$56.38M
YoY Change	-21.98%	-5.71%	-5.71%
Other Long-Term Liabilities	$2.576M	$2.689M	$54.74M
YoY Change	664.39%	364.42%	-82.13%
Total Long-Term Liabilities	$2.576M	$2.689M	$111.1M
YoY Change	664.39%	364.42%	-69.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.28M	$31.47M	$31.47M
Total Long-Term Liabilities	$2.576M	$2.689M	$111.1M
Total Liabilities	$56.41M	$142.6M	$142.6M
YoY Change	-79.68%	-62.91%	-62.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$807.5M	-$808.9M
YoY Change	-6.57%	-14.94%
Common Stock	$480.0K	$480.0K
YoY Change	3.67%	7.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.46M	-$2.576M	$35.08M
YoY Change
Total Liabilities & Shareholders Equity	$158.5M	$177.7M	$177.7M
YoY Change	-15.72%	-10.68%	-10.68%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$1.324M	$11.56M	$142.1M
YoY Change	-98.47%	-86.31%	-146.98%
Depreciation, Depletion And Amortization	$236.0K	$234.0K	$985.0K
YoY Change	-10.27%	-27.1%	-20.5%
Cash From Operating Activities	-$19.85M	-$17.39M	-$66.31M
YoY Change	-1.54%	47.31%	18.25%
INVESTING ACTIVITIES
Capital Expenditures	$57.00K	$57.00K	$312.0K
YoY Change	-141.61%	-142.22%	-248.57%
Acquisitions
YoY Change
Other Investing Activities	$30.00M	$7.407M	$27.19M
YoY Change	51.51%	16.12%	-118.31%
Cash From Investing Activities	$29.95M	$7.350M	$26.88M
YoY Change	52.28%	17.71%	-118.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-807.0K	10.35M	41.76M
YoY Change	-113.35%	-243.87%	-81.02%
NET CHANGE
Cash From Operating Activities	-19.85M	-17.39M	-66.31M
Cash From Investing Activities	29.95M	7.350M	26.88M
Cash From Financing Activities	-807.0K	10.35M	41.76M
Net Change In Cash	9.292M	309.0K	2.332M
YoY Change	67.42%	-102.42%	-84.71%
FREE CASH FLOW
Cash From Operating Activities	-$19.85M	-$17.39M	-$66.31M
Capital Expenditures	$57.00K	$57.00K	$312.0K
Free Cash Flow	-$19.91M	-$17.44M	-$66.62M
YoY Change	-0.58%	49.5%	19.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001616543
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20221231#DepositsAndOtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20221231#DepositsAndOtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20221231#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20221231#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://www.senseonics.com/20221231#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://www.senseonics.com/20221231#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	479637138
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	447282263
CY2021Q4	sens	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
CY2021Q4	sens	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2021Q4	sens	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	447282263
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	479637138
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	12000
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37717
CY2022	dei	Entity Registrant Name EntityRegistrantName	SENSEONICS HOLDINGS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1210911
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	20451 Seneca Meadows Parkway
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876-7005
CY2022	dei	City Area Code CityAreaCode	301
CY2022	dei	Local Phone Number LocalPhoneNumber	515-7260
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	SENS
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022Q4	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	3108000
CY2021Q4	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	1086000
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	463000000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	479780414
CY2022	dei	Auditor Firm AuditorFirmId	185
CY2021	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	KPMG LLP
CY2022	dei	Auditor Location AuditorLocation	McLean, Virginia
CY2021	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2021	dei	Auditor Location AuditorLocation	Tysons, Virginia
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35793000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33461000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	108222000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	96445000
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	127000
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	205000
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	2324000
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	1768000
CY2022Q4	us-gaap	Inventory Net InventoryNet	7306000
CY2021Q4	us-gaap	Inventory Net InventoryNet	6316000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7428000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6218000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	161200000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	144413000
CY2021Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	239000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	12253000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	51882000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1112000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1308000
CY2022Q4	us-gaap	Assets Assets	177673000
CY2021Q4	us-gaap	Assets Assets	198928000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	419000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1204000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	14616000
CY2021Q4	sens	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	10667000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Current From Related Parties AccruedLiabilitiesAndOtherLiabilitiesCurrentFromRelatedParties	837000
CY2021Q4	sens	Accrued Liabilities And Other Liabilities Current From Related Parties AccruedLiabilitiesAndOtherLiabilitiesCurrentFromRelatedParties	3597000
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	15579000
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	20000
CY2021Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	2926000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31471000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18394000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	56383000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	59798000
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	52050000
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	236291000
CY2021Q4	sens	Long Term Options LongTermOptions	69401000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2689000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	579000
CY2022Q4	us-gaap	Liabilities Liabilities	142593000
CY2021Q4	us-gaap	Liabilities Liabilities	384463000
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	12000
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2022Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	37656000
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	37656000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	479637138
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	447282263
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	480000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	447000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	806488000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	765215000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-678000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-212000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-808866000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-950985000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2576000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-185535000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	177673000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	198928000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	656000
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	15733000
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	12281000
CY2020	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3581000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1394000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1368000
CY2022	us-gaap	Revenues Revenues	16389000
CY2021	us-gaap	Revenues Revenues	13675000
CY2020	us-gaap	Revenues Revenues	4949000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13663000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14486000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22315000
CY2022	us-gaap	Gross Profit GrossProfit	2726000
CY2021	us-gaap	Gross Profit GrossProfit	-811000
CY2020	us-gaap	Gross Profit GrossProfit	-17366000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39719000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27217000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20413000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31634000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	29154000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	41351000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-68627000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-57182000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-79130000
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1824000
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	243000
CY2020	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	175000
CY2022	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	43745000
CY2021	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	-53152000
CY2020	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	-30721000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	-101000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	330000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	-21112000
CY2020	sens	Loss On Issuance Of Debt And Other Issuance Cost LossOnIssuanceOfDebtAndOtherIssuanceCost	12706000
CY2022	us-gaap	Interest Expense InterestExpense	18703000
CY2021	us-gaap	Interest Expense InterestExpense	16720000
CY2020	us-gaap	Interest Expense InterestExpense	16167000
CY2020	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	1216000
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	184221000
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-174173000
CY2020	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-11641000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	138000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1647000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2339000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-102000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-173000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-311000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	210746000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-245292000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-96038000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	142119000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-302474000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-175168000
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-466000
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-212000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-466000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-212000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	141653000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-302686000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-175168000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	467952475
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	422321023
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	227912358
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	618205605
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	422321023
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	227912358
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-8649000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-26000
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	576000
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	27259000
CY2020	sens	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options And Restricted Stock Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAndRestrictedStockRequisiteServicePeriodRecognition	7314000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4611000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-175168000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-144083000
CY2021	sens	Shares Issued During Period Value Conversion Of Temporary Equity SharesIssuedDuringPeriodValueConversionOfTemporaryEquity	45565000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200365000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4993000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6501000
CY2021	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	74000
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5293000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	9029000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-302474000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-212000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-185535000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	34174000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	951000
CY2022	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	133000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8618000
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2570000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	142119000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-466000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2576000
CY2022	us-gaap	Profit Loss ProfitLoss	142119000
CY2021	us-gaap	Profit Loss ProfitLoss	-302474000
CY2020	us-gaap	Profit Loss ProfitLoss	-175168000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	985000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1239000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1141000
CY2022	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	12164000
CY2021	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	8462000
CY2020	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	10977000
CY2022	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	-184221000
CY2021	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	174173000
CY2020	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	11641000
CY2022	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	43745000
CY2021	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	-53152000
CY2020	sens	Nonoperating Gain Loss Fair Value Adjustment NonoperatingGainLossFairValueAdjustment	-30721000
CY2022	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	-101000
CY2021	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	330000
CY2020	sens	Gains Losses On Extinguishment Of Debt And Gain Loss On Stock Conversion GainsLossesOnExtinguishmentOfDebtAndGainLossOnStockConversion	-21112000
CY2020	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	12706000
CY2021	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	518000
CY2022	sens	Impairment Of Options ImpairmentOfOptions	-138000
CY2021	sens	Impairment Of Options ImpairmentOfOptions	-1647000
CY2020	sens	Impairment Of Options ImpairmentOfOptions	-2339000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	8618000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	9029000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	7314000
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-10000
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-181000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	478000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1013000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7393000
CY2022	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	1210000
CY2021	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	2444000
CY2020	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-737000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	989000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1036000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-11648000
CY2022	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	-381000
CY2021	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	164000
CY2020	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	-117000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-785000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-559000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2522000
CY2022	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	1462000
CY2021	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	2218000
CY2020	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-6585000
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-95000
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	372000
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-379000
CY2022	sens	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-757000
CY2021	sens	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-904000
CY2020	sens	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-795000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66312000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-56078000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-67422000
CY2020	us-gaap	Notes Issued1 NotesIssued1	15675000
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	312000
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	210000
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	181000
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	104706000
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	154514000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	131900000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5975000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	26882000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-148749000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-181000
CY2022	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	34174000
CY2021	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	200365000
CY2020	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	-26000
CY2022	sens	Proceeds From Exercise Of Stock Options Stock Warrants And Espp Purchases ProceedsFromExerciseOfStockOptionsStockWarrantsAndEsppPurchases	1084000
CY2021	sens	Proceeds From Exercise Of Stock Options Stock Warrants And Espp Purchases ProceedsFromExerciseOfStockOptionsStockWarrantsAndEsppPurchases	5066000
CY2020	sens	Proceeds From Exercise Of Stock Options Stock Warrants And Espp Purchases ProceedsFromExerciseOfStockOptionsStockWarrantsAndEsppPurchases	576000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2570000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5293000
CY2020	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	55971000
CY2020	sens	Payments Of Notes Payable Issuance Costs PaymentsOfNotesPayableIssuanceCosts	601000
CY2022	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	12000000
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	22783000
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2926000
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2838000
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	66050000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41762000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	220083000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10130000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2332000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15256000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-77733000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33461000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18205000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95938000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35793000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33461000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18205000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	6568000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	7822000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	4726000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2689000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30000
CY2022	sens	Conversion Of Options Into Redeemable Convertible Preferred Stock ConversionOfOptionsIntoRedeemableConvertiblePreferredStock	25656000
CY2021	sens	Conversion Of Options Into Redeemable Convertible Preferred Stock ConversionOfOptionsIntoRedeemableConvertiblePreferredStock	19973000
CY2021	sens	Common Stock Issued Converted From Preferred Shares CommonStockIssuedConvertedFromPreferredShares	54166000
CY2021	sens	Common Stock Issued1 CommonStockIssued1	4925000
CY2020	sens	Common Stock Issued1 CommonStockIssued1	227000
CY2020	sens	Proceeds From Issuance Of Common Stock And Warrants In Connection With Highbridge Transactions ProceedsFromIssuanceOfCommonStockAndWarrantsInConnectionWithHighbridgeTransactions	55303000
CY2020	sens	Proceeds From Issuance Of Common Stock In Connection With Energy Capital ProceedsFromIssuanceOfCommonStockInConnectionWithEnergyCapital	3399000
CY2020	us-gaap	Notes Reduction NotesReduction	24000000
CY2022	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	166000
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">1.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">Organization</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Senseonics Holdings, Inc., a Delaware corporation, is a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="white-space:pre-wrap;"> Senseonics, Incorporated is a wholly owned subsidiary of Senseonics Holdings, Inc. and was originally incorporated on October 30, 1996 and commenced operations on January 15, 1997. Senseonics Holdings, Inc. and Senseonics, Incorporated are hereinafter collectively referred to as the “Company” unless otherwise indicated or the context otherwise requires.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;"></span></p>
CY2022	us-gaap	Gross Profit GrossProfit	2700000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-808900000
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	156300000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="font-weight:bold;margin-left:0pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenues and expenses. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
CY2022Q4	us-gaap	Cash Cash	1135000
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	108000
CY2021	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	704000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	781000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	723000
CY2021Q4	us-gaap	Cash Cash	4264000
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	34658000
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	29197000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35793000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33461000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	0
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	0
CY2022Q4	us-gaap	Time Sharing Transactions Allowance For Uncollectible Accounts TimeSharingTransactionsAllowanceForUncollectibleAccounts	0
CY2021	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	781000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	723000
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	646000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;margin:0pt;"><b style="font-weight:bold;">Derivative Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;margin:0pt;"> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;text-indent:36pt;margin:0pt;">The Company accounts for conversion options embedded in convertible notes in accordance with ASC Topic 815, Derivatives and Hedging. ASC Topic 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free standing derivative financial instruments. We review the terms of convertible debt issues to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as separate derivative instruments. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:10.0pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;text-indent:36pt;margin:0pt;">The fair value of the embedded features are accounted for as a derivative liability in the Company’s consolidated balance sheets and adjusted to fair value each reporting period. The change in fair value of derivatives is recorded as a component of other income (expense) in the Company’s consolidated statements of operations and comprehensive loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:10.0pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;text-indent:36pt;margin:0pt;">When the equity or convertible debt instruments contain embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those instruments being recorded at a discount from their face value. The discount from the face value of the convertible debt, together with the stated interest on the instrument, is amortized over the term of the instrument as interest expense.</p>
CY2022	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Product Warranty Obligations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company provides a warranty of one year on its smart transmitters. Additionally, the Company may also replace Eversense system components that do not function in accordance with the product specifications. Estimated replacement costs are recorded at the time of shipment as a charge to cost of sales in the consolidated statement of operations and are developed by analyzing product performance data and historical replacement experience, including comparing actual return management authorizations to revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">At December 31, 2022 and December 31, 2021, the warranty reserve was $0.8 million and $0.7 million, respectively. The following table provides a reconciliation of the change in estimated warranty liabilities for the years ended December 31, 2022 and 2021 (in thousands):</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:10.0pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:22.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:middle;width:52.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:24.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;visibility:hidden;"></span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance at beginning of the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 723</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 646</p></td></tr><tr><td style="vertical-align:bottom;width:52.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Provision for warranties during the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 166</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 781</p></td></tr><tr><td style="vertical-align:bottom;width:52.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Settlements made during the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (108)</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (704)</p></td></tr><tr><td style="vertical-align:bottom;width:52.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance at end of the period</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:22.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 781</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 723</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:10.0pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;"></span></p>
CY2022	sens	Product Warranty Term ProductWarrantyTerm	P1Y
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	800000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	700000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2021	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2022	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2022	us-gaap	Revenues Revenues	16389000
CY2022	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2021	us-gaap	Revenues Revenues	13675000
CY2021	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2020	us-gaap	Revenues Revenues	4949000
CY2020	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1700000
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1800000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	142119000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-302474000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-175168000
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	-209269000
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-67150000
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-302474000
CY2020	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-175168000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.77
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.77
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	467952475
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	422321023
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	227912358
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2411337
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	618205605
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	422321023
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	227912358
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12345350
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	149382078
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	173222308
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	121153000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	678000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	120475000
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	148539000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	212000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	148327000
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	108797000
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	108222000
CY2022Q4	sens	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year Two DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearTwo	5620000
CY2022Q4	sens	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo	5608000
CY2022Q4	sens	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year Three DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearThree	6736000
CY2022Q4	sens	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Three DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearThree	6645000
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	121153000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	120475000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1697000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1012000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4057000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3770000
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1552000
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1534000
CY2022Q4	us-gaap	Inventory Net InventoryNet	7306000
CY2021Q4	us-gaap	Inventory Net InventoryNet	6316000
CY2022Q4	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	4097000
CY2021Q4	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	5036000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1243000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	74000
CY2022Q4	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	924000
CY2021Q4	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	142000
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	336000
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	443000
CY2022Q4	sens	Prepaid Accounting And Audit PrepaidAccountingAndAudit	270000
CY2022Q4	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	189000
CY2021Q4	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	225000
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	158000
CY2021Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	98000
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	132000
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	105000
CY2022Q4	sens	Research And Development ResearchAndDevelopment	67000
CY2021Q4	sens	Research And Development ResearchAndDevelopment	39000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	12000
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	56000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7428000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6218000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3150000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2838000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2038000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1530000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1112000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1308000
CY2022	us-gaap	Depreciation Depreciation	500000
CY2021	us-gaap	Depreciation Depreciation	500000
CY2020	us-gaap	Depreciation Depreciation	400000
CY2022	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	0
CY2021	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	100000
CY2020	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	300000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4699000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3484000
CY2022Q4	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	3502000
CY2021Q4	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	2145000
CY2022Q4	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	2480000
CY2021Q4	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	914000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2050000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2144000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1053000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1011000
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	781000
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1697000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	725000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	904000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	149000
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1962000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3000
CY2022Q4	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	15453000
CY2021Q4	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	14264000
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	500000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	900000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	900000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3032000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	821000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	725000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	904000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2689000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	579000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3414000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1483000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1006000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	709000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	730000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	752000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	774000
CY2022Q4	sens	Lessee Operating Lease Liability Payment Due Year Six LesseeOperatingLeaseLiabilityPaymentDueYearSix	327000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4298000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	884000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3414000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.091
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.091
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1000000.0
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	400000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	6539000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11773000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	391000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	18703000
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	6882000
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9475000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	299000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3183000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	19839000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	15700000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	35000000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	51199000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	101899000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	479637138
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	447282263
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	12000
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	sens	Number Of Voting Classes NumberOfVotingClasses	1
CY2022Q4	sens	Temporary Equity Voting Right Per Share Price TemporaryEquityVotingRightPerSharePrice	1000
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	1.24
CY2022Q4	sens	Voting Right Percentage Cap VotingRightPercentageCap	0.290
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15775000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.16
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	224000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.98
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2355000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.61
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	260000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.06
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13384000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M15D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	449000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.48
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	974000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.98
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1080000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.52
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11779000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y25D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	11138000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.48
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y10M13D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.04
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.97
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.33
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	974285
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2354566
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	201447
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000000.0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4400000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2100000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3100000
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	400000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	400000
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.29
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.58
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.63
CY2022	sens	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue	0.59
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	1.06
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	133031000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	125242000
CY2022Q4	sens	Deferred Tax Assets Capitalized Start Up Costs DeferredTaxAssetsCapitalizedStartUpCosts	6538000
CY2021Q4	sens	Deferred Tax Assets Capitalized Start Up Costs DeferredTaxAssetsCapitalizedStartUpCosts	7315000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	13121000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	11251000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	8853000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1695000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2061000
CY2022Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	5136000
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	8853000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2143000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	912000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	170517000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	155634000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	163255000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	146463000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7262000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9171000
CY2022Q4	sens	Deferred Tax Liability Amortization Right Of Use Asset DeferredTaxLiabilityAmortizationRightOfUseAsset	896000
CY2021Q4	sens	Deferred Tax Liability Amortization Right Of Use Asset DeferredTaxLiabilityAmortizationRightOfUseAsset	318000
CY2022Q4	sens	Deferred Tax Liability Amortization Of Debt Discount DeferredTaxLiabilityAmortizationOfDebtDiscount	6366000
CY2021Q4	sens	Deferred Tax Liability Amortization Of Debt Discount DeferredTaxLiabilityAmortizationOfDebtDiscount	8853000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7262000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9171000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16800000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10400000
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	621500000
CY2022Q4	sens	Operating Loss Carryforwards Subject To Expiry OperatingLossCarryforwardsSubjectToExpiry	197500000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0040
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0160
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0232
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.0132
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0034
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0046
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0218
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0085
CY2022	sens	Effective Income Tax Rate Reconciliation Nondeductible Expense Debt And Other Issuance Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtAndOtherIssuanceCostPercent	-0.3168
CY2021	sens	Effective Income Tax Rate Reconciliation Nondeductible Expense Debt And Other Issuance Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtAndOtherIssuanceCostPercent	-0.1709
CY2020	sens	Effective Income Tax Rate Reconciliation Nondeductible Expense Debt And Other Issuance Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtAndOtherIssuanceCostPercent	-0.1115
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0200
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0101
CY2022	sens	Effective Income Tax Rate Reconciliation Nondeductible Expense Officers Compensation Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficersCompensationPercent	-0.0168
CY2021	sens	Effective Income Tax Rate Reconciliation Nondeductible Expense Officers Compensation Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficersCompensationPercent	0.0096
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.0021
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.0050
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.0044
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1171
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0322
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1134
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2813000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2552000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2351000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	505000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	267000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	201000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	38000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	6000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3280000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2813000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2552000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	224037000
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	84117000
CY2022	sens	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Financial Instruments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfFinancialInstruments	25656000
CY2021	sens	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Financial Instruments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfFinancialInstruments	19973000
CY2022	sens	Fair Value Measurement With Unobservable Inputs Reconciliation Gain Loss On Fair Value Adjustment FairValueMeasurementWithUnobservableInputsReconciliationGainLossOnFairValueAdjustment	-43745000
CY2021	sens	Fair Value Measurement With Unobservable Inputs Reconciliation Gain Loss On Fair Value Adjustment FairValueMeasurementWithUnobservableInputsReconciliationGainLossOnFairValueAdjustment	53152000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	178425000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-108606000
CY2022	sens	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Loss On Extinguishment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLossOnExtinguishment	-101000
CY2021	sens	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Loss On Extinguishment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLossOnExtinguishment	3513000
CY2022	sens	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Financial Asset Impairment Cost FairValueMeasurementWithUnobservableInputsReconciliationRecurringFinancialAssetImpairmentCost	138000
CY2021	sens	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Financial Asset Impairment Cost FairValueMeasurementWithUnobservableInputsReconciliationRecurringFinancialAssetImpairmentCost	1648000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	81417000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	5817000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	52050000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	224037000
CY2021Q4	sens	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0

Files In Submission

Name	View Source	Status
sens-20221231_cal.xml	Edgar Link	unprocessable
0001558370-23-003952-index-headers.html	Edgar Link	pending
0001558370-23-003952-index.html	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
sens-20221231_def.xml	Edgar Link	unprocessable
0001558370-23-003952.txt	Edgar Link	pending
0001558370-23-003952-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sens-20221231.xsd	Edgar Link	pending
sens-20221231x10k.htm	Edgar Link	pending
sens-20221231x10k004.jpg	Edgar Link	pending
sens-20221231x10k005.jpg	Edgar Link	pending
sens-20221231xex10d10.htm	Edgar Link	pending
sens-20221231xex10d11.htm	Edgar Link	pending
sens-20221231xex23d1.htm	Edgar Link	pending
sens-20221231xex23d2.htm	Edgar Link	pending
sens-20221231xex31d1.htm	Edgar Link	pending
sens-20221231xex31d2.htm	Edgar Link	pending
sens-20221231xex32d1.htm	Edgar Link	pending
sens-20221231x10k_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
sens-20221231_pre.xml	Edgar Link	unprocessable
sens-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SENS
Senseonics Holdings, Inc. Stock $sens

2023 Q1 Form 10-K Financial Statement

#000155837023003952 Filed on March 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS Senseonics Holdings, Inc. Stock $sens

2023 Q1 Form 10-K Financial Statement

#000155837023003952 Filed on March 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS
Senseonics Holdings, Inc. Stock $sens